Lyric Self-replacement Clinical Investigation

NCT ID: NCT05349981

Last Updated: 2023-07-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

57 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-07-29

Study Completion Date

2023-03-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is designed to investigate the effectiveness and safety of the Phonak Lyric self-replacement procedure, as compared to the HCP-replacement procedure.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hearing Loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Self-controlled repeated measures study design with a single cohort, intended to mimic clinical use case.
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lyric self-replacement

This cohort of experienced Lyric patients are required to meet the candidacy criteria to be eligible for the self-replacement procedure. They will also be required to demonstrate proficiency with the self-replacement procedure before proceeding with independent self-replacement.

Group Type EXPERIMENTAL

Phonak Lyric self-replacement procedure

Intervention Type DEVICE

The self-replacement procedure is an experimental procedure in which the Lyric user replaces the Lyric devices independently at every other device replacement, using dedicated candidacy, training, and management procedures, conducted by and at the discretion of his/her hearing care provider (HCP).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Phonak Lyric self-replacement procedure

The self-replacement procedure is an experimental procedure in which the Lyric user replaces the Lyric devices independently at every other device replacement, using dedicated candidacy, training, and management procedures, conducted by and at the discretion of his/her hearing care provider (HCP).

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Meets requirements outlined on Lyric self-replacement candidacy form
* Current Lyric hearing instrument user with 3+ months of Lyric experience
* 22 years of age or older at the time of enrollment in the study
* Mild-to-moderately severe sensorineural hearing loss (bilaterally or unilaterally)
* Good understanding (read/write/speak) of the English language
* Willingness to comply with all study requirements

Exclusion Criteria

* Does not meet requirements outlined on Lyric self-replacement candidacy form
* Difficulty understanding/reading instructions when corrected for vision loss
* Impairments that would restrict participation in any of the evaluations
* Ear health conditions present at baseline that prevent immediate device replacement
* Conditions that would indicate the need for medical referral prior to hearing aid fitting according to local regulations
Minimum Eligible Age

22 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AccuData Solutions

UNKNOWN

Sponsor Role collaborator

Sonova AG

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Grace Gardner, AuD

Role: STUDY_DIRECTOR

Sonova USA Inc

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

San Francisco Audiology

San Francisco, California, United States

Site Status

NYC Hearing Associates

New York, New York, United States

Site Status

Aim Hearing and Audiology

Greensboro, North Carolina, United States

Site Status

ENT & Audiology Associates

Raleigh, North Carolina, United States

Site Status

The Woodlands Hearing Center

The Woodlands, Texas, United States

Site Status

Bay Area Audiology and Hearing Aids

Webster, Texas, United States

Site Status

Richmond Hearing Doctors

Midlothian, Virginia, United States

Site Status

Richmond Hearing Doctors

Richmond, Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0700

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Evaluation of Hearing Aid Benefit
NCT05198713 COMPLETED NA